Newsletter Subject

Premium Tech Insights for the Week of November 12...

From

strategictechinvestor.com

Email Address

customerservice@strategictechinvestor.com

Sent On

Mon, Nov 19, 2018 01:05 AM

Email Preheader Text

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiv

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Strategic Tech Investor. Your ability to alter your subscription information can be found at the bottom of this email. [Strategic Tech Investor] [The Best (and Simplest) Method for a Shot at Crypto Riches]( cryptocurrency industry has minted millionaires by the dozen - and today, you have a chance to join their ranks. If you take the leap now, you could grab an enormous chunk of this unprecedented windfall opportunity. [Keep reading](... --------------------------------------------------------------- November 18, 2018 Dear Strategic Tech Investor Reader, The news appears grim. Today, arthritis affects about 54 million American adults. And it's not just folks in their 60s and 70s - a growing number of people in their 50s and 40s are getting it, too. By 2040, the CDC expects 11.4% of the entire U.S. population will say they can't participate in certain activities due to arthritis. That last figure actually might be too conservative, as the principal risk factor - at least the one people can control - is being overweight or obese. And I hate to tell you, if current obesity trends in our youth continue, more than 57% of today's young people will be obese by the age of 35, according to a 2017 study from the Harvard T.H. Chan School of Public Health. Fortunately, [help is on the way](. Approval from the U.S. Food and Drug Administration approval is around the corner for [one firm]( that's developing a special arthritis treatment. And it's got some serious blockbuster profit potential. I'm talking about [a tiny biotech]( that could be bigger than Pfizer Inc. ([NYSE:PFE]() in a matter of days. This treatment could make you $1.4 million overnight. [Check it out](. Meanwhile, I've been covering the biotech sector - and much more - in my premium services: [Nova-X Report]( and [Radical Technology Profits](. To check out what we've been looking at this week, just check out the links below. [Did You Catch this 35% One-Day Gain?]( Last month, we discussed a brilliant merger/acquisition play. As I told you, "bringing these two firms together creates one of the most dynamic new business models to emerge in some time." Since the deal was announced in mid-October, shares of the acquirer moved lower as investors questioned the generous $2 billion price tag on the deal. Now, that price looks like a profound bargain. This past week, both firms reported that their businesses are firing on all cylinders, growing even faster that we first thought. That double-barrel, bright outlook caused shares of the acquirer to surge a stunning 35% this past Wednesday. That adds on to the already-stunning gains we've seen for this stock. [And that's not our only big winner in this topsy-turvy week](... [As Massachusetts Opens Dispensary Doors, Here's How to Play It]( It's taken a couple of years, but Massachusetts dispensaries are finally ready to open their doors. In fact, Massachusetts marijuana stores should open by Thanksgiving. That's great news for cannabis company investors, as the firms behind legal cannabis sales in the Bay State could be stepping into a $1.8 billion recreational market. For years, legal recreational cannabis was mostly a "West Coast"/"Rocky Mountain" thing. Washington and Colorado became the first states to legalize recreational cannabis in 2012. Since then, California, Nevada, and Oregon have followed their lead. Back on the East Coast, Massachusetts and Maine also legalized in 2016 - but Massachusetts is just getting started now. So why the longer-than-average delay? [Read on](... [The World's Top Oil Companies Are Flocking to Blockchain]( About a year ago, a group of the large oil companies, and their banks and trading houses, formed an alliance to launch Vakt, a blockchain-driven platform for energy commodity training. On Monday, Vakt's product developer said the platform will now launch by the end of the month in the North Sea oil market. And that's just the beginning for this blockchain platform. I believe these trading systems will be digitized entirely within in the next decade. [So you can bet we'll be watching to see how Vakt progresses](... [More Firms Are Relying on This Cyber Defender]( They are relentless. They're creating trouble 24 hours a day, 365 days per year. They're bringing major organizations to a standstill. In fact, they recently wrought havoc for the city of Atlanta and all the residents that rely on local government. I'm talking about cyber thieves. They deploy a range of tricks to get people to click on links, opening the door to vicious attacks on computer networks. Thankfully, firms large and small are getting wise, installing special software that can help protect against this onslaught. By one measure, spending on such protection surged 30% from a year ago. And that's where our protector of corporate emails comes in. [Check it out](... [Why I'm Recommending These Lucrative "Blueprint" Plays]( A new blueprint from President Donald Trump is aimed at reducing drug prices. It's all laid in a 47-page report in which President Trump aims to save the U.S. an estimated $47 billion in drug costs. In the blueprint, the president makes it clear that he wants the FDA to speed up approval of generic copies of brand-name drugs. But here's what the president's report doesn't reveal... There are billions in profits up for grabs here. And that means savvy investors with the right game plan can make fast triple-digit gains from drugs that are about to go off patent. [And that's where today's plays come in](... If you [Nova-X Report]( and [Radical Technology Profits]( members haven't caught up on my critical alerts, then take a look. For those of you who aren't yet members, all you need to do is click on the research service or alert that interests you. Then we'll show you how to gain immediate access to that service. Soon after, you'll start getting every single alert, special report, and newsletter the moment they're ready. Of course, there are many more benefits of becoming a member - so I hope you'll check these out. I'll be back next week with more. Cheers and good investing, Michael A. Robinson --------------------------------------------------------------- [Facebook]( [Twitter]( [More...]( mailto:?subject=Michael%20Robinson's%20Strategic%20Tech%20Investor&body=Check%20out%20http%3A%2F%2Fwww.strategictechinvestor.com%2F You are receiving this e-mail at, {EMAIL}, as a part of your free subscription to Strategic Tech Investor. Remove your email from this list: [Unsubscribe]( [Manage Your Email Preferences]( To cancel by mail or for any other subscription issues, write us at: Strategic Tech Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 [Contact Customer Service]( Website: [( © 2018 Strategic Tech Investor All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Strategic Tech Investor. 1125 N Charles Street, Baltimore MD 21201.

Marketing emails from strategictechinvestor.com

View More
Sent On

29/07/2020

Sent On

23/07/2020

Sent On

15/07/2020

Sent On

08/07/2020

Sent On

01/07/2020

Sent On

25/06/2020

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.